This protocol addresses the management of alpha thalassemia minor specifically in the setting of non-deletional haemoglobin H (HbH) disease — a clinical scenario in which affected individuals present with notably diverse phenotypes.
Patients with non-deletional haemoglobin H (HbH) disease exhibit a wide range of clinical phenotypes. This variability shapes how management is structured for this subpopulation, making a tailored, protocol-driven approach particularly important.
Nutritional supplementation forms the basis of management in this setting and is recommended across all age groups. The specific agents, quantities, and full protocol details are available in the complete regimen below.